STATs信号转导通路与靶基因研究进展
被引量:3
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
2009年第10期892-894,共3页
Cancer Research on Prevention and Treatment
基金
国家自然科学基金资助项目(30271269)
参考文献26
-
1Klampfer L. Signal transducers and activators of transcription (STATs) : Novel targets of chemopreventive and chemothera peutic drugs[J]. Curr Cancer Drug Targets, 2006, 6(2):107 -121.
-
2Ferrajoli A, Faderl S, Ravandi F, et al. The JAK-STAT pathway: a therapeutic target in hematological malignancies [J]. Curt Cancer Drug Targets, 2006, 6(8):671- 679.
-
3Knudsen KE, Diehl JA, Haiman CA, el al. Cyclin D1:polymorphism, aberrant splicing and cancer risk[J]. Oncogene, 2006, 25(11 ): 1620-1628.
-
4Leslie K, Lang C, Devgan G, et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3[J]. Cancer Res, 2006, 66(5):2544 -2552.
-
5Leeman RJ, Lui VW, Grandis JR. STAT3 as a therapeutic target in head and neck cancer[J]. Expert Opin Biol Ther, 2006, 6(3) :231-241.
-
6Duan Z, Foster R, Bell DA, et al. Signal transducers and activators of transcription 3 pathway activation in drug resistant o varian cancer[J]. Clin Cancer Res, 2006, 12 (17) : 5055-5063.
-
7Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene[J]. Cell, 1999, 98(3):295-303.
-
8Bott SR, Arya M, Kirby RS, et al. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation[J]. Prostate Cancer Prostatic Dis, 2005, 8 (4): 321-326.
-
9Bellido T, O'Brien CA, Roberson PK, et al. Transcriptional activation of the p21 (WAF1, CIPI, SDI 1 ) gene by interleukin- 6 type cytokines. A prerequisite for their pro-differentiating and anti apoptotic effects on human osteoblastic cells[J]. J Biol Chem, 1998, 273(33):21137 -21144.
-
10Bowman T, Broome MA, Sinibaldi D, et al. Stat3-mediated Myc expression is required for Src transformation and PDGF- induced mitogenesis[J]. Proc Natl Acad Sci USA, 2001, 98 (13) :7319-7324.
同被引文献30
-
1马向涛,王杉,杜如昱,叶颖江,崔志荣.Stat3反义寡核苷酸联合化疗调控结肠癌细胞增殖与凋亡的分子机制[J].中华实验外科杂志,2004,21(10):1212-1214. 被引量:25
-
2Bromberg JF, Wrzeszczynska MH, Devgan G, et al.Stat3 as an oncogene[J].Cell, 1999, 98(3):295-303.
-
3Bewry NN, Nair RR, Emmons MF, et al.Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance[J].Mol Cancer Ther, 2008, 7(10):3169-3175.
-
4Klampfer L.Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs[J].Curr Cancer Drug Targets, 2006, 6(2): 107-121.
-
5Alvarez JV, Greulich H, Sellers WR, et al.Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer- associated mutations of the epidermal growth factor receptor[J].Cancer Res, 2006, 66(6): 3162-3168.
-
6Gu F, Ma Y, Zhang Z, et al.Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma[J].Oncol Rep, 2010, 23(3):671-676.
-
7Rosen DG, Mercado-Uribe I, Yang G, et al.The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis [J].Cancer, 2006, 107(11):2730-2740.
-
8Duan Z, Ames RY, Ryan M, et al.CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells[J].Cancer Chemother Pharmacol, 2009, 63(4):681-689.
-
9Kim JH, Lee SC, Ro J, et al.Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines [J].Biochem Pharmacol, 2010, 79(3):373-380.
-
10Kunigal S, Lakka SS, Sodadasu PK, et al.Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer[J].Int J Oncol, 2009, 34(5):1209-1220.
引证文献3
-
1冯雪,郑建华.卵巢癌化疗耐药相关细胞信号转导通路的研究进展[J].妇产与遗传(电子版),2012,2(1):35-38. 被引量:3
-
2马向涛.STAT3信号转导通路与肿瘤耐药研究进展[J].肿瘤防治研究,2011,38(4):474-475. 被引量:2
-
3徐莎,许震宇,王越,刘厚奇.HIV-1反式激活蛋白介导的白血病抑制因子受体α亚基胞内区远膜端融合蛋白在HL-60细胞分化中对microRNA-155的影响[J].解剖学杂志,2014,37(4):454-457.
二级引证文献5
-
1徐莎,许震宇,王越,刘厚奇.HIV-1反式激活蛋白介导的白血病抑制因子受体α亚基胞内区远膜端融合蛋白在HL-60细胞分化中对microRNA-155的影响[J].解剖学杂志,2014,37(4):454-457.
-
2许冠华,雷俊华,金丽莎,陈喆.隐丹参酮联合顺铂作用于非小细胞肺癌PC9细胞的体外研究[J].浙江中西医结合杂志,2014,24(12):1043-1045. 被引量:9
-
3张婷婷.P65、P50及IκBα表达与卵巢癌化疗耐药性的相关性研究[J].国际检验医学杂志,2018,39(21):2689-2691. 被引量:3
-
4崔若凌,管越,辛彤,康妍,冯华.中医药调控相关信号通路在抑制卵巢癌中的作用机制[J].航空航天医学杂志,2024,35(3):333-336. 被引量:1
-
5杨晶珍,刘海清,张剑.卵巢癌耐药机制的研究进展[J].中国老年学杂志,2015,35(4):1117-1120. 被引量:9
-
1马向涛.STATs信号转导通路与实体瘤研究进展[J].肿瘤防治研究,2008,35(2):135-138. 被引量:2
-
2汤欣,韩凤娟,隆康健,吴效科.STAT3信号通路在卵巢癌中的研究进展[J].世界中西医结合杂志,2012,7(3):260-262. 被引量:2
-
3史娜,于利人,陈立军,靳秋月.RNAi沉默STAT3对结直肠癌SW480细胞的抑制作用及其机制[J].中国肿瘤生物治疗杂志,2014,21(1):44-48. 被引量:3
-
4吴明彩,毕富勇.反义STAT3与肿瘤基因治疗[J].皖南医学院学报,2008,27(6):448-451.
-
5何文琼,殷霞丽,谢丽,禹立霞,钱晓萍,赖仁胜,魏嘉,刘宝瑞.STAT3单核苷酸多态性与胃癌生物学行为的相关性研究[J].南京医科大学学报(自然科学版),2009,29(11):1481-1484. 被引量:1
-
6人类白血病诱导分化和凋亡的细胞及分子机制研究[J].中国肿瘤,1997,6(5):22-22. 被引量:1
-
7董硕,陈竺,王振义.染色体易位与人类白血病[J].国外医学(内科学分册),1993,20(6):268-270.
-
8韩玉娟.远离白血病 预防为主[J].抗癌之窗,2014(3):24-25.
-
9阎影,曹履先.人类白血病和淋巴瘤中的癌基因和抗癌基因[J].山西白血病,1993,2(2):108-110.
-
10Kelsey SM,肖志坚.维生素D与人类白血病[J].国外医学(输血及血液学分册),1989,12(5):268-268.